Omega Healthcare Investors, Inc. (OHI) Stock: A Look at the Monthly Trend

In the past week, OHI stock has gone down by -2.73%, with a monthly decline of -2.82% and a quarterly surge of 1.42%. The volatility ratio for the week is 1.35%, and the volatility levels for the last 30 days are 1.64% for Omega Healthcare Investors, Inc. The simple moving average for the past 20 days is -3.74% for OHI’s stock, with a -4.78% simple moving average for the past 200 days.

Is It Worth Investing in Omega Healthcare Investors, Inc. (NYSE: OHI) Right Now?

The price-to-earnings ratio for Omega Healthcare Investors, Inc. (NYSE: OHI) is above average at 30.44x. The 36-month beta value for OHI is also noteworthy at 0.91. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 8 rating it as “hold,” and 2 rating it as “sell.”

The public float for OHI is 244.58M, and at present, short sellers hold a 5.49% of that float. The average trading volume of OHI on April 18, 2024 was 1.80M shares.

OHI) stock’s latest price update

Omega Healthcare Investors, Inc. (NYSE: OHI) has seen a decline in its stock price by -0.50 in relation to its previous close of 30.11. However, the company has experienced a -2.73% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-17 that Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Analysts’ Opinion of OHI

Many brokerage firms have already submitted their reports for OHI stocks, with Citigroup repeating the rating for OHI by listing it as a “Buy.” The predicted price for OHI in the upcoming period, according to Citigroup is $35 based on the research report published on March 22, 2024 of the current year 2024.

Wells Fargo, on the other hand, stated in their research note that they expect to see OHI reach a price target of $35, previously predicting the price at $31. The rating they have provided for OHI stocks is “Overweight” according to the report published on February 26th, 2024.

Exane BNP Paribas gave a rating of “Neutral” to OHI, setting the target price at $30 in the report published on February 08th of the current year.

OHI Trading at -2.91% from the 50-Day Moving Average

After a stumble in the market that brought OHI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.83% of loss for the given period.

Volatility was left at 1.64%, however, over the last 30 days, the volatility rate increased by 1.35%, as shares sank -3.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.27% upper at present.

During the last 5 trading sessions, OHI fell by -2.73%, which changed the moving average for the period of 200-days by -2.38% in comparison to the 20-day moving average, which settled at $31.07. In addition, Omega Healthcare Investors, Inc. saw -2.28% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for OHI

Current profitability levels for the company are sitting at:

  • 0.71 for the present operating margin
  • 0.95 for the gross margin

The net margin for Omega Healthcare Investors, Inc. stands at 0.25. The total capital return value is set at 0.08. Equity return is now at value 6.74, with 2.61 for asset returns.

Based on Omega Healthcare Investors, Inc. (OHI), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 1.42. The interest coverage ratio of the stock is 2.89.

Currently, EBITDA for the company is 828.95 million with net debt to EBITDA at 5.5. When we switch over and look at the enterprise to sales, we see a ratio of 12.61. The receivables turnover for the company is 0.55for trailing twelve months and the total asset turnover is 0.1.

Conclusion

In summary, Omega Healthcare Investors, Inc. (OHI) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts